Associazione Oasi Maria S.S.Onlus
- Address
- lock Available on a paid plan
Congenital, Hereditary, and Neonatal Diseases
At Associazione Oasi Maria S.S.Onlus in Troina, research in this therapeutic area focuses on inherited and developmental conditions affecting children and families, with a strong emphasis on Down syndrome. The trials are designed to explore new ways to improve everyday functioning, behavior, and quality of life.
- Behavioral and cognitive impairments in Down syndrome
- Testing a potential therapy to improve adaptive behaviors
- Evaluating whether treatment benefits are meaningful across different patient groups
This work reflects a broader effort to develop better supportive treatments for neurodevelopmental disorders and related genetic conditions.
Nervous System Diseases
Clinical research at this site also covers nervous system diseases, especially epilepsy-related disorders and Rett syndrome. These studies aim to assess how well new or existing treatments can reduce seizures and support neurological function in people with complex brain disorders.
- Refractory partial onset epilepsy and focal onset seizures
- Rett syndrome and treatment response
- Comparing therapies to see whether they improve seizure control or overall symptoms
The research includes evaluating treatment effectiveness and safety, with the goal of offering more reliable options for patients living with difficult-to-control neurological conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Aelis Farma1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Associazione Oasi Maria S.S.Onlus
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of AEF0217 in Treating Behavioral and Cognitive Impairments in Adults and Adolescents with Down Syndrome: A Phase 2B Randomized Controlled Trial | Aelis Farma | Phase II | Recruiting | Dec 2025 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 1-((3S,8S,9S,10R,13S,14S,17S)3-BENZYLOXY-10,13,17-TRIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1HCYCLOPENTA[A]PHENANTHRENE-17-YL)ETHAN-1-ONE | 1 | Unknown | 2025-12-11 | 2025-12-11 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.